Results 1 to 10 of about 432,821 (259)
What role for real-world evidence in market access of biosimilars? [PDF]
Frontiers in PharmacologyCatherine Lockhart +2 more
exaly +2 more sources
Market Structure And Market Access [PDF]
World Economy, 2007 We examine an issue at the nexus of domestic competition policy and international trade, the interaction between goods trade and market power in domestic trade and distribution sectors. Theory suggests a set of linkages between service-sector competition and goods trade supported by econometrics involving imports of 22 OECD countries vis-´a-vis 69 ...
Francois, Joseph, Wooton, Ian
openaire +9 more sources
Market access and welfare: Is there a conflict? [PDF]
Economics Letters, 2014 zbMATH Open Web Interface contents unavailable due to conflicting licenses.
Raimondos-Møller, P, Woodland, AD
openaire +5 more sources
The AIFA time-to-reimbursement: a comparison between the last two committees from 2015 to 2020
Global & Regional Health Technology Assessment, 2020 Objective. To compare the time-to-reimbursement of the last two committees of the Italian Medicines Agency (AIFA), respectively appointed in 2015 and in 2018. Methods.
Paola Raimondo +6 more
doaj +1 more source
Journal of Pharmaceutical Policy and Practice, 2021 Background Advanced therapy medicinal products (ATMPs) represent an important cornerstone for innovation in healthcare. However, uncertainty on the value, the high average cost per patient and their one-shot nature has raised a debate on their assessment
Virginia Ronco +4 more
doaj +1 more source
Access to Medicines, Access to Markets [PDF]
Frontiers in Sociology, 2020 This article explores some uses by the pharmaceutical industry of language from the "access to medicines" movement in global health, sometimes for goals almost completely opposite to those of the movement. Important in the context of extremely expensive treatments, the industry draws on the idealistic discourse around access to medicines to create a ...
openaire +3 more sources
Choosing formulas for market access negotiations: efficiency and market access considerations [PDF]
, 2005 An important issue in multilateral trade negotiations is the approach taken to reduce tariffs. The authors believe that there are important advantages in formula approaches and survey a range of options between the sharply top-down Swiss formula and proportional cuts in tariffs.
Francois, J., Martin, W., Manole, V.
openaire +5 more sources
Oncology and Therapy, 2023 Introduction Extrapolating long-term overall survival (OS) from shorter-term clinical trial data is key to health technology assessment in oncology. However, extrapolation using conventional methods is often subject to uncertainty.
Stephen Palmer +12 more
doaj +1 more source
Early access according to Law 648: a review for the clinician
AboutOpen, 2023 Law 648 has been introduced in Italy in 1996. It allows early access and off label use of novel drugs that fulfill important unmet medical needs. Despite being live for almost twenty years, there are still several areas where the clinician does not have ...
Valentina Drago, Federica Giuffrida
doaj +1 more source
AboutOpen, 2021 Background: Enterosorbents are orally administered materials which pass through the gut where they bind various substances. In a randomized clinical trial, the efficacy and safety of enterosorbent Enterosgel® in the treatment of non-infectious diseases ...
Roberto Ravasio, Paola Raimondo
doaj +1 more source